What Researchers Did
Researchers at a tertiary referral center compared the clinical management and treatment outcomes of patients with sudden sensorineural hearing loss (SSNHL) before and during the COVID-19 pandemic.
What They Found
The study found similar demographic characteristics, comorbidities, and time to hospital admission for SSNHL patients across both periods. Treatment responses, assessed by Siegel's criteria, also showed a similar trend, although systemic steroid and hyperbaric oxygen therapy use decreased during the pandemic, while antiviral use increased.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss should continue to seek prompt medical attention, as the pandemic did not significantly alter treatment outcomes or the urgency of care. While treatment approaches may have shifted during the pandemic, the overall effectiveness for SSNHL appears to have remained consistent.
Canadian Relevance
This study was conducted at a tertiary referral center outside of Canada, and therefore has no direct Canadian connection.
Study Limitations
The study's findings are based on data from a single tertiary referral center, which may limit the generalizability of the results.